The Controversy Around Convalescent Plasma And COVID-19  — Explained

Ultimately, anything that’s given a EUA should be subjected to more clinical trials in the future. “No one knows how much plasma to give, who is a good donor, when is the best time in the disease course to transfuse convalescent plasma, how much, if any it actually improves survival, who are the best candidates for convalescent plasma, and whether it should be tried in combination with other therapies,” Caplan wrote. All that information should be gathered in controlled, peer-reviewed studies.

Molly Longman Read More